BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21144060)

  • 21. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells.
    Caria P; Dettori T; Frau DV; Lichtenzstejn D; Pani F; Vanni R; Mai S
    J Cell Physiol; 2019 Apr; 234(4):5175-5185. PubMed ID: 30328617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells.
    Zahn M; Marienfeld R; Melzner I; Heinrich J; Renner B; Wegener S; Mießner A; Barth TF; Dorsch K; Brüderlein S; Möller P
    Blood; 2017 Mar; 129(11):1480-1490. PubMed ID: 28082443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
    Heine B; Hummel M; Demel G; Stein H
    J Pathol; 1999 Jun; 188(2):139-45. PubMed ID: 10398156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease.
    Elenitoba-Johnson KS; Medeiros LJ; Khorsand J; King TC
    Am J Clin Pathol; 1996 Dec; 106(6):728-38. PubMed ID: 8980348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reed-Sternberg cells in Hodgkin's cell lines HDLM, L-428, and KM-H2 are not actively replicating: lack of bromodeoxyuridine uptake by multinuclear cells in culture.
    Hsu SM; Zhao X; Chakraborty S; Liu YF; Whang-Peng J; Lok MS; Fukuhara S
    Blood; 1988 May; 71(5):1382-9. PubMed ID: 3359046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
    Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
    Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel automated three-dimensional genome scanning based on the nuclear architecture of telomeres.
    Klewes L; Höbsch C; Katzir N; Rourke D; Garini Y; Mai S
    Cytometry A; 2011 Feb; 79(2):159-66. PubMed ID: 21265009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
    Reynolds DJ; Banks PM; Gulley ML
    Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomere maintenance by telomerase and by recombination can coexist in human cells.
    Cerone MA; Londono-Vallejo JA; Bacchetti S
    Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
    Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
    Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
    van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
    Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the origin of H/RS cell and their biological behavior in Hodgkin lymphoma by using multiple mark techniques].
    Wang JF; Xi YF; Wang LX; Yin WD; Zhang JW; Gong FC
    Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):579-82. PubMed ID: 15634588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
    Oshima Y; Puri RK
    Cell Immunol; 2001 Jul; 211(1):37-42. PubMed ID: 11585386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin's Lymphoma.
    Knecht H; Righolt C; Mai S
    Cancers (Basel); 2013 Jun; 5(2):714-25. PubMed ID: 24216998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
    Kim LH; Nadarajah VS; Peh SC; Poppema S
    Histopathology; 2004 Mar; 44(3):257-67. PubMed ID: 14987230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.